SCHEMBL7165495

SCHEMBL7165495

CCC#C[C@@]1(OC(=O)c2ccccc2)[C@@H](COC(=O)c2ccccc2)O[C@@H](n2ccc(N)nc2=O)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ST6GAL1 P15907 4/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ NT5E P21589 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GAPDH P04406 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7166943 0.92 NT5E (0.38) ST6GAL1L3MBTL1LMNATHRBMTOR
SCHEMBL7157425 0.88 NT5E (0.40) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7161805 0.85 POLB (0.41) ALDH1A1NT5EMEN1USP2POLB
SCHEMBL7031520 0.81 LMNA (0.33) L3MBTL1LMNATHRBMTORMDM2
SCHEMBL16131588 0.81 ST6GAL1 (0.40) ST6GAL1L3MBTL1LMNATHRBMTOR
SCHEMBL7158886 0.80 ST6GAL1 (0.40) ST6GAL1LMNATHRBMTORMDM2
SCHEMBL7161168 0.78 ALDH1A1 (0.40) LMNAALDH1A1MEN1USP2POLB
SCHEMBL7161159 0.78 ALDH1A1 (0.39) LMNAALDH1A1POLB
SCHEMBL12702718 0.77 LMNA (0.41) ST6GAL1L3MBTL1LMNATHRBMTOR
SCHEMBL7165048 0.76 ALDH1A1 (0.36) ALDH1A1NT5EHTTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747389-B1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2003-09-10 — — EP disclosed
US-RE38090-E1 Antitumor activity; useful for treatment and prevention of cancers Matsuda, Akira (JP) 2003-04-22 — — US disclosed
US-5763418-A NUCLEOTIDE ANTITUMOR AGENTS Matsuda, Akira (JP) 1998-06-09 — — US disclosed
EP-0747389-A1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-12-11 — — EP disclosed
Send feedback